| ACSF | Artificial cerebrospinal fluid |
| AD | Alzheimer’s disease |
| AFM | Atomic force microscopy |
| AMCA | 7 Amino-4-methylcoumarin-3-acetic acid |
| ANOVA | Analysis of variance |
| ApoE | Apolipoprotein E |
| APP | Amyloid precursor protein |
| Aβ | Beta-amyloid |
| CA | Cornu Ammonis |
| EOAD | Early-onset AD |
| ER | Endoplasmic reticulum |
| fAβ | Fibrillar form of Aβ |
| fEPSP | Field excitatory postsynaptic potential |
| HC | Hippocampus |
| HCBS | Hydrocarbonate buffered saline |
| icv | Intracerebroventricular |
| LOAD | Late-onset AD |
| LTP | Long term potentiation |
| MEA | Multi-electrode array |
| MWM | Morris water maze |
| NFTs | Neurofibrillary tangles |
| oAβ | Oligomeric form of Aβ |
| PBS | Phosphate-buffered saline solution |
| PCA-AD | Posterial cortical atrophy variant of AD |
| PSEN1, 2 | Presenilin-1 and 2 |
| r-AD | Rapidy progressive form of AD |
| t-AD | Typical prolonged-duration form of AD |
| TBS | Theta-burst stimulation |